Sanofi (SNYNF)

Market Cap	113.67B -15.7%
Revenue (ttm)	54.85B +5.5%
Net Income	9.17B +40.5%
EPS	7.48 +43.6%
Shares Out	n/a
PE Ratio	12.39
Forward PE	9.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,501
Average Volume	1,573
Open	93.85
Previous Close	93.84
Day's Range	93.85 - 93.85
52-Week Range	85.74 - 113.69
Beta	0.32
RSI	55.97
Earnings Date	Apr 23, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for onc...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 74,846
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNYNF

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR